OccuLogix Inc.
11025 Roselle Street
Suite 100
San Diego,
CA 92121
United States - Map
Phone: 858-455-6006
Fax: 858-812-0540
Web Site: http://www.occulogix.com
| OccuLogix, Inc., an ophthalmic device company, engages in commercializing a proprietary in vitro diagnostic tear testing platform, the TearLab test for dry eye disease. Its TearLab Osmolarity System enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The companys TearLab Osmolarity System consists of the TearLab disposable, a single-use microfluidic labcard; the TearLab pen, a hand-held device, which interfaces with the TearLab disposable; and the TearLab reader, a small desktop unit that allows for the docking of the TearLab disposable and the TearLab pen, as well as provides a quantitative reading for the operator. It has operations in the United States, Canada, Europe, and Israel. OccuLogix, Inc. was founded in 1996 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Elias Vamvakas , 50
Chairman and Interim Chief Exec. Officer |
N/A
| N/A | Mr. William G. Dumencu C.A., 54
Chief Financial Officer and Treasurer |
N/A
| N/A | Mr. Benjamin Sullivan Ph.D., 33
Chief Scientific Officer |
$
180.00K | N/A | Mr. Robert Walder , 58
VP of Operations |
N/A
| N/A | Dr. Stephen Westing Ph.D.,
VP of Medical and Scientific Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.23% Nasdaq 0.00%
Profile
